Effect of 8 Weeks Moderate & High Intensity Training on Cognitive Functions and Sleep of Female Students
NCT06230094, Not applicable, Unknown, Riphah International University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Effect of 8 Weeks Moderate & High Intensity Training on Cognitive Functions and Sleep of Female Students | ClinicalTrials.gov |
| NCT number | NCT06230094 | ClinicalTrials.gov |
| Status | Unknown | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 32 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Riphah International University | ClinicalTrials.gov |
| Conditions | Sleep, Cognition | ClinicalTrials.gov |
| Interventions | moderate intensity, high intensity | ClinicalTrials.gov |
| First posted | 2024-01-30 | ClinicalTrials.gov |
| Last updated | 2024-01-30 | ClinicalTrials.gov |
Registered outcomes 4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Stroop test for Cognitive Function | 8 weeks | The Stroop Color and Word Test, interference on reading ability through three sections: word page, color page, and word-color page, each containing 5 columns with 20 items. In a 45-second timeframe, participants rapidly read words or name ink colors. Overall, the Stroop test offers a comprehensive evaluation of cognitive abilities related to interference and reading skills. | ClinicalTrials.gov |
| Primary | Pittsburg sleep quality index , | 8 weeks | Each of the seven component scores, encompassing subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction, is assigned a value on a scale ranging from 0 to 3. A score of 0 signifies an absence of difficulty, while a score of 3 reflects severe difficulty within the specific component. The calculation of the Global Pittsburgh Sleep Quality Index (PSQI) score involves summing up these seven component scores, resulting in a total score that ranges from 0 to 21. Elevated global scores are indicative of lower sleep quality, and a score exceeding 5 is generally construed as suggestive of poor sleep. In terms of interpretation, a global PSQI score falling between 0 and 5 is considered representative of "good" sleep quality, while a score surpassing 5 implies a lower quality of sleep. | ClinicalTrials.gov |
| Primary | Digit span test | 8 weeks | The Digit Span Test gauges short-term memory and attention span by having individuals repeat digit sequences in the same or reverse order. Scores are assigned per correctly repeated digit, with the test progressively increasing in difficulty. The total score reflects the longest accurately recalled sequences in both conditions. Interpretation reveals insights into working memory and attentional control, where a higher Digit Span Forward score signifies efficient short-term memory, while a higher Digit Span Backward score indicates superior working memory and cognitive flexibility in recalling and manipulating sequences in reverse order. | ClinicalTrials.gov |
| Primary | Sleep quality scale | 8 weeks | The Sleep Quality Scale (SQS) measures sleep quality in people who live in the general population. Using a four-point, Likert-type scale, respondents indicate how frequently they exhibit certain sleep behaviors (0 = "few," 1 = "sometimes," 2 = "often," and 3 = "almost always"). Scores on items belong to factors 2 and 5 (restoration after sleep and satisfaction with sleep) and are reversed before being tallied. Total scores can range from 0 to 84, with higher scores demoting more acute sleep problems. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 2
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Digit Span Test | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)